Onkos Surgical, a provider of services for complex orthopedic conditions, has acquired the Juvenile Tumour System from Stryker.
JTS enables limb stabilization and growth in pediatric patients affected by bone cancers and malignant diseases.
“This is a significant day for Onkos Surgical and the musculoskeletal oncology community,” said Patrick Treacy, CEO of Onkos. “Our ‘Why’ has always driven us to specifically address the many clinical challenges this community of surgeons and patients face daily. Pediatric cancer surgery and limb lengthening are complex and challenging procedures, and the JTS extendible prosthesis is a solution in service of this mission. We are committed to being good stewards of the technology.”